Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

131 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial.
Aguilar-Guisado M, Espigado I, Martín-Peña A, Gudiol C, Royo-Cebrecos C, Falantes J, Vázquez-López L, Montero MI, Rosso-Fernández C, de la Luz Martino M, Parody R, González-Campos J, Garzón-López S, Calderón-Cabrera C, Barba P, Rodríguez N, Rovira M, Montero-Mateos E, Carratalá J, Pérez-Simón JA, Cisneros JM. Aguilar-Guisado M, et al. Among authors: gudiol c. Lancet Haematol. 2017 Dec;4(12):e573-e583. doi: 10.1016/S2352-3026(17)30211-9. Epub 2017 Nov 15. Lancet Haematol. 2017. PMID: 29153975 Clinical Trial.
Prospective study of fecal colonization by extended-spectrum-beta-lactamase-producing Escherichia coli in neutropenic patients with cancer.
Calatayud L, Arnan M, Liñares J, Dominguez MA, Gudiol C, Carratalà J, Batlle M, Ribera JM, Gudiol F. Calatayud L, et al. Among authors: gudiol c, gudiol f. Antimicrob Agents Chemother. 2008 Nov;52(11):4187-90. doi: 10.1128/AAC.00367-08. Epub 2008 Sep 22. Antimicrob Agents Chemother. 2008. PMID: 18809942 Free PMC article.
Bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome.
Gudiol C, Calatayud L, Garcia-Vidal C, Lora-Tamayo J, Cisnal M, Duarte R, Arnan M, Marin M, Carratalà J, Gudiol F. Gudiol C, et al. Among authors: gudiol f. J Antimicrob Chemother. 2010 Feb;65(2):333-41. doi: 10.1093/jac/dkp411. Epub 2009 Dec 3. J Antimicrob Chemother. 2010. PMID: 19959544
Effect of statins on outcomes in immunosuppressed patients with bloodstream infection.
Viasus D, Gudiol C, Fernández-Sabé N, Cabello I, Garcia-Vidal C, Cisnal M, Duarte R, Antonio M, Carratalà J. Viasus D, et al. Among authors: gudiol c. Eur J Clin Microbiol Infect Dis. 2011 Jan;30(1):77-82. doi: 10.1007/s10096-010-1056-2. Epub 2010 Sep 12. Eur J Clin Microbiol Infect Dis. 2011. PMID: 20835878
Risk factors for, and clinical relevance of, faecal extended-spectrum β-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies.
Arnan M, Gudiol C, Calatayud L, Liñares J, Dominguez MÁ, Batlle M, Ribera JM, Carratalà J, Gudiol F. Arnan M, et al. Among authors: gudiol c, gudiol f. Eur J Clin Microbiol Infect Dis. 2011 Mar;30(3):355-60. doi: 10.1007/s10096-010-1093-x. Epub 2010 Oct 30. Eur J Clin Microbiol Infect Dis. 2011. PMID: 21052757
131 results